Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Aghili, Rokhsareh ^a   Khamseh, Mohammad E ^a   Malek, Mojtaba ^a   Yarahmadi, Shahin ^b   Farshchi, Amir ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cost analysis; Diabetes; Structured self monitoring of blood glucose

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; COST BENEFIT ANALYSIS; FEMALE; GENERAL PRACTITIONER; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT CARE; SELF MONITORING; SELF MONITORING OF BLOOD GLUCOSE;

EID: 84868121890     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-32     Document Type: Article

References (29)

1. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, et al. J Diabetes Sci Technol 2008 2 6 1030 1053 19885292
2. The Global Burden (Accessed May 1 2012), http://www.idf.org/ diabetesatlas/5e/the-global-burden
3. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW, Diabetes Care 2008 31 1 96 98 17921357
4. The role of environmental pollution of pesticides in human diabetes. Mostafalou S, Abdollahi M, Int J Pharmacol 2012 8 2 139 140 10.3923/ijp.2012. 139.140
5. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. Parkin CG, Davidson JA, J Diabetes Sci Technol 2009 3 3 500 508 20144288
6. Tight glycaemic control: the key to improving the management of type 2 diabetes. Alberti G, Br J Diabetes Vasc Dis 2005 5 184 185 10.1177/ 14746514050050040101 (Pubitemid 41320543)
7. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, BMJ 2000 321 7258 405 412 10.1136/bmj.321.7258.405 10938048 (Pubitemid 30609442)
8. Self-monitoring of blood glucose: is it worth it? Jarvis S, Br J Diabetes Vasc Dis 2005 5 5 245 246 10.1177/14746514050050050101 (Pubitemid 41723700)
9. Parkin Christopher G, Paired testing regimens facilitate effective use of self-monitoring of blood glucose Prepared for Roche Diagnostics Corporation (Accessed May 01 2012), 2009 https://www.accu-chekconnect.com/hcpstatic/ documents/clinical-evidence/Paired-Testing-WhitePaper.pdf
10. Self-monitoring of blood glucose: benefits and utilization. Austin MM, Haas L, Johnson T, Parkin CG, Parkin CL, Spollett G, Volpone MT, Diabetes Educ 2006 32 6 835 836 844-837 10.1177/0145721706295873 17102152 (Pubitemid 44706814)
11. Self-monitoring of blood-glucose. Improvement of diabetic control. Walford S, Gale EA, Allison SP, Tattersall RB, Lancet 1978 1 8067 732 735 76746 (Pubitemid 8303168)
12. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA, Diabetologia 2006 49 2 271 278 10.1007/s00125-005-0083-5 16362814 (Pubitemid 43185395)
13. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the united states. Tunis SL, Minshall ME, Am J Manag Care 2008 14 3 131 140 18333705 (Pubitemid 351367356)
14. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents. Pollock RF, Valentine WJ, Goodall G, Brandle M, Swiss Med Wkly 2010 140 13103 21110238
15. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A, BMJ 2008 336 7654 1177 1180 10.1136/bmj.39526.674873.BE 18420663 (Pubitemid 351809279)
16. [Cost-effectiveness analysis of self-monitoring of blood glucose in type 2 diabetics]. Clua Espuny JL, Puig Junoy J, Queralt Tomas ML, Palau Galindo A, Gac Sanit 2000 14 6 442 448 11270170
17. Primary care in the United States: primary care gatekeeping and referrals: effective filter or failed experiment? Forrest CB, BMJ 2003 326 7391 692 695 10.1136/bmj.326.7391.692 12663407 (Pubitemid 36390450)
18. Quality incentives: the case of U.K. general practitioners. Smith PC, York N, Health Aff (Millwood) 2004 23 3 112 118 10.1377/hlthaff.23.3.112 (Pubitemid 38638996)
19. Health reform and healthcare homes:the role of community health centers. Hawkins DR, Proser MP, Schwartz R, Harvard Health Pol Rev 2007 8 2 1 12
20. Ministry of Health and Medical Education (Accessed May 07 2012), http://medcare.behdasht.gov.ir/index.aspx?siteid=312&pageid=30144
21. Central Bank of Iran (Accessed May 07 2012), www.cbi.ir/exrates/rates-fa. aspx
22. Cost-Effectiveness analysis. Rasccati Karen L, Essentials of Pharmacoeconomics Lippincott Williams & Wilkins, Philadelphia, Rasccati Karen L, 2009 59
23. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, Sadeghi A, PLoS One 2011 6 10 26864 10.1371/journal.pone.0026864 22066013
24. Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR TS. Holko P, Kawalec P, Diabetes Metab Syndr Obes 2011 4 79 88 21448325
25. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, Petersen B, Schweitzer M, Wagner RS, Diabetes Care 2011 34 2 262 267 10.2337/dc10-1732 21270183
26. Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic? Ho M, Marger M, Beart J, Yip I, Shekelle P, Diabetes Care 1997 20 4 472 475 10.2337/diacare.20.4.472 9096962 (Pubitemid 27143397)
27. Managed care and capitation in California: how do physicians at financial risk control their own utilization? Kerr EA, Mittman BS, Hays RD, Siu AL, Leake B, Brook RH, Ann Intern Med 1995 123 7 500 504 7661493
28. Smith E, Brugha R, Zwi A, Working with private sector providers for better health care: an introductory guide (Accessed May 07 2012), http://www.who.int/management/partnerships/private/privatesectorguide.pdf
29. What are the equity, efficiency, cost containment and choice implications of private health-care funding in western Europe? (Accessed May 07 2012), http://www.euro.who.int/-data/assets/pdf-file/0003/74694/E83334.pdf